Halozyme Therapeutics Inc. (HALO)
Market Closed
16 Oct, 08:00 PM
$
121. 84
+0.33
+0.2716%
$
13.79B Market Cap
20.87 P/E Ratio
- Div Yield
2.08M Volume
2.74 Eps
$ 121.51
Previous Close 
Want to track HALO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Halozyme Therapeutics Inc. (HALO) Statistics
Valuation metrics
Market Cap 13.79B
Enterprise value 15.81B
Trailing P/E (ttm) 34.61
Forward P/E 6.91
PEG ratio -1.62
Price/Sales (ttm) 8.31
Price/Book (mrq) 99.54
Enterprise Value/Revenue 9.5
Enterprise Value/EBITDA 22.01
Overview
Shares outstanding 118.52M
Float 117.28M
Shares short 14.38M
% Held by insiders 0.01%
% Held by institutions 1.08%
Average volume (10 days) 2.28M
Average volume (90 days) 2.24M
Price summary
52-Week low 61.23
52-Week high 122.45
Beta 0.88
50-Day moving average 110.7
200-Day moving average 85.03
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 171:40
Last split Date 10 Dec 2003
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.25%
Operating margin 0.56%
Operational effectiveness
Return on assets 0.16%
Return on equity 1.81%
Income Statement
Revenue (ttm) 1.51B
Revenue per share (ttm) 14.19
Quarterly revenue growth (yoy) 0.42%
Gross profit (ttm) 1.16B
EBITDA 946.91M
Net income to common (ttm) 348.84M
Diluted EPS (ttm) 3.53
Quarterly earnings growth (yoy) 0.27%
Balance Sheet
Total cash (mrq) 318.62M
Total cash per share (mrq) 1.97
Total debt (mrq) 2.18B
Total Debt/Equity (mrq) 14.95
Current ratio (mrq) 2.71%
Book value per share (mrq) 1.22
Cash Flow
Cash flow statement 677.41M
Levered free cash flow (LFCF) 228.12M
2026 © Marketlog. All Rights Reserved.
